Mast Cell
A tissue-resident immune cell that contains granules packed with histamine, heparin, and inflammatory mediators. Mast cells play essential roles in allergic responses and wound healing but are also the cell of origin for mast cell tumors — one of the most common skin cancers in dogs.
Mast cells are tissue-resident immune cells derived from bone marrow precursors that migrate to and mature in connective tissues throughout the body. They are most densely concentrated in tissues that interface with the external environment — skin, respiratory mucosa, gastrointestinal lining, and around blood vessels. Mast cells contain cytoplasmic granules loaded with preformed mediators: histamine, heparin, serotonin, proteases (tryptase, chymase), and cytokines (TNF-alpha, interleukins).
Normal Functions
Mast cells serve several physiological roles:
- Allergic and hypersensitivity responses: IgE antibodies bound to mast cell surface receptors (FcepsilonRI) trigger degranulation when they encounter their specific allergen. Released histamine causes vasodilation, increased vascular permeability, smooth muscle contraction, and mucus secretion — the hallmarks of allergic reactions. This pathway drives atopic dermatitis, skin allergies, and food allergies in dogs.
- Innate immune defense: Mast cells recognize pathogens through toll-like receptors and release antimicrobial peptides and cytokines that recruit neutrophils and other immune cells to sites of infection.
- Wound healing: Histamine and growth factors released by mast cells promote angiogenesis, fibroblast proliferation, and tissue repair.
- Parasite defense: Mast cell degranulation in the gut is part of the defense against intestinal parasites.
Mast Cells and Mast Cell Tumors
Mast cell tumors (MCTs) arise from neoplastic proliferation of mast cells and represent one of the most common skin tumors in dogs, accounting for approximately 16-21% of all cutaneous tumors. MCTs are clinically unpredictable — they can appear as small, innocent-looking bumps or aggressive, ulcerated masses.
Breeds with elevated MCT risk include Boxers, Labrador Retrievers, Golden Retrievers, Boston Terriers, and Pugs. Boxers tend to develop lower-grade MCTs with better prognosis, while breeds like Shar Peis often develop more aggressive variants.
Because MCTs contain histamine-laden granules, manipulation of the tumor (handling, surgery, biopsy) can trigger local or systemic histamine release, causing:
- Local swelling and redness (Darier’s sign)
- Gastrointestinal ulceration (histamine stimulates gastric acid secretion)
- Hypotension in severe cases
Grading and Prognosis
MCT grading by histopathology is the single most important prognostic factor:
- Low grade (Kiupel two-tier system): Slow-growing, high cure rate with complete surgical excision
- High grade: Aggressive, high metastatic potential, often requiring surgery plus chemotherapy and/or radiation
Longevity Relevance
Early detection through fine-needle aspirate (FNA) of any new skin lump is the primary longevity lever for MCTs. Low-grade MCTs caught early and excised with adequate margins have cure rates exceeding 90%. Delayed diagnosis allows potential metastasis to lymph nodes, liver, and spleen, dramatically reducing survival time. Regular skin checks and a “aspirate every lump” approach are standard recommendations for all dogs, especially predisposed breeds.